Skip to main content
RACS ASC 2026
Exercise Programs in Breast Cancer Patients
Poster

Poster

Disciplines

Breast Surgery

Presentation Description

Institution: Sir Charles Gairdner Hospital - WA, Australia

BACKGROUND Breast cancer is a major global issue and most prevalent malignancy diagnosed in women worldwide as of 2020 [1]. Exercise is a key modifiable factor known to improve physical, psychological, and functional outcomes for breast cancer survivors. This study aimed to assess the feasibility, acceptability, and patient preferences regarding a structured exercise program offered during routine breast cancer surveillance. METHODS An approved survey was distributed to breast cancer survivors attending a tertiary breast clinic for annual surveillance. Participants completed the questionnaire while waiting in clinic. The survey explored willingness to participate in an exercise program, preferred types of exercise, program location, perceived barriers, and interest in additional supportive services. RESULTS A total of 101 participants completed the survey. Interest in an exercise program was high, with approximately 60% indicating they would “definitely” or “probably” participate. Cardiovascular and combined cardio–strength training were the most preferred exercise types. Off-site facilities near the hospital were the favoured program location, followed by on-site options. Nearly half of respondents reported no barriers to participation; when present, barriers most commonly related to transport or time constraints. The majority did not desire additional services beyond an exercise program. CONCLUSION Breast cancer survivors demonstrated strong interest in structured exercise programs, with diverse activity preferences and relatively few perceived barriers. These findings support the feasibility of integrating exercise oncology into routine follow-up care, with potential to enhance survivorship outcomes. REFERENCES 1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. https://doi.org/10.3322/caac.21660
Presenters
Authors
Authors

Dr Deanna Lee - , Dr Yang Yang Huang - , Dr Kallyani Ponniah - , Mr Ben Kramer -